Maria Sklodowska-Curie National Research Institute of Oncology
🇵🇱Poland
- Country
- 🇵🇱Poland
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.pib-nio.pl/
Dr Jurczak on the Efficacy and Safety of Nemtabrutinib in R/R Follicular Lymphoma
Wojciech Jurczak, MD, PhD, from the Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, presents BELLWAVE-003 study findings on nemtabrutinib in relapsed or refractory follicular lymphoma at the 2024 ASH Annual Meeting.
New Data to be Presented from EFTISARC-NEO Phase II Evaluating Novel Triple
Immutep announces new data from EFTISARC-NEO Phase II trial of eftilagimod alpha in combination with radiotherapy and KEYTRUDA® for soft tissue sarcoma to be presented at CTOS 2024 Annual Meeting.
New Data to be Presented from EFTISARC-NEO Phase II
EFTISARC-NEO trial results of efti, radiotherapy, and KEYTRUDA® to be presented at CTOS 2024. First trial to evaluate efti in neoadjuvant setting for soft tissue sarcoma, showing promising initial efficacy. STS has high unmet medical need and poor prognosis.
© Copyright 2024. All Rights Reserved by MedPath